药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzphetamine
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Posaconazole.
Benzphetamine
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Posaconazole.
Benzphetamine
Inotersen
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Inotersen.
Benzphetamine
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pipemidic acid.
Benzphetamine
Rufloxacin
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Rufloxacin.
Benzphetamine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Piromidic acid.
Benzphetamine
Lorajmine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lorajmine.
Benzphetamine
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxolinic acid.
Benzphetamine
Prajmaline
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prajmaline.
Benzphetamine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cibenzoline.
Benzphetamine
Cicletanine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cicletanine.
Benzphetamine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pilsicainide.
Benzphetamine
Givinostat
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Givinostat.
Benzphetamine
Temefos
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Temefos.
Benzphetamine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prulifloxacin.
Benzphetamine
CUDC-907
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with CUDC-907.
Benzphetamine
Anisodamine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Anisodamine.
Benzphetamine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pazufloxacin.
Benzphetamine
Bilastine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bilastine.
Benzphetamine
Difloxacin
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Difloxacin.